v3.26.1
CONDENSED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in-Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024 38,665,583      
Beginning balance at Dec. 31, 2024 $ 143,625      
Ending balance (in shares) at Mar. 31, 2025 38,665,583      
Ending balance at Mar. 31, 2025 $ 143,625      
Beginning balance (in shares) at Dec. 31, 2024   2,090,945    
Beginning balance at Dec. 31, 2024 (129,510) $ 2 $ 838 $ (130,350)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercises of stock options (in shares)   87,549    
Issuance of common stock upon exercises of stock options 34   34  
Stock-based compensation 152   152  
Net loss (5,375)     (5,375)
Ending balance (in shares) at Mar. 31, 2025   2,178,494    
Ending balance at Mar. 31, 2025 $ (134,699) $ 2 1,024 (135,725)
Beginning balance (in shares) at Dec. 31, 2024 38,665,583      
Beginning balance at Dec. 31, 2024 $ 143,625      
Ending balance (in shares) at Jun. 30, 2025 38,665,583      
Ending balance at Jun. 30, 2025 $ 143,625      
Beginning balance (in shares) at Dec. 31, 2024   2,090,945    
Beginning balance at Dec. 31, 2024 $ (129,510) $ 2 838 (130,350)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercises of stock options (in shares) 353,223      
Net loss $ (10,000)      
Ending balance (in shares) at Jun. 30, 2025   2,459,183    
Ending balance at Jun. 30, 2025 $ (138,986) $ 2 1,362 (140,350)
Beginning balance (in shares) at Mar. 31, 2025 38,665,583      
Beginning balance at Mar. 31, 2025 $ 143,625      
Ending balance (in shares) at Jun. 30, 2025 38,665,583      
Ending balance at Jun. 30, 2025 $ 143,625      
Beginning balance (in shares) at Mar. 31, 2025   2,178,494    
Beginning balance at Mar. 31, 2025 (134,699) $ 2 1,024 (135,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercises of stock options (in shares)   265,674    
Issuance of common stock upon exercises of stock options 95   95  
Issuance of common stock upon exercises of warrants (in shares)   15,015    
Issuance of common stock upon exercises of warrants 73   73  
Stock-based compensation 170   170  
Net loss (4,625)     (4,625)
Ending balance (in shares) at Jun. 30, 2025   2,459,183    
Ending balance at Jun. 30, 2025 $ (138,986) $ 2 1,362 (140,350)
Beginning balance (in shares) at Dec. 31, 2025 0      
Beginning balance at Dec. 31, 2025 $ 0      
Ending balance (in shares) at Mar. 31, 2026 0      
Ending balance at Mar. 31, 2026 $ 0      
Beginning balance (in shares) at Dec. 31, 2025 46,865,051 46,865,051    
Beginning balance at Dec. 31, 2025 $ 13,260 $ 47 168,878 (155,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon Private Placement, net of issuance cost (in shares)   2,867,089    
Issuance of common stock upon Private Placement, net of issuance cost 13,620 $ 3 13,617  
Issuance of common stock upon exercises of stock options (in shares)   106,727    
Issuance of common stock upon exercises of stock options 39   39  
Stock-based compensation 334   334  
Net loss (7,033)     (7,033)
Ending balance (in shares) at Mar. 31, 2026   49,838,867    
Ending balance at Mar. 31, 2026 $ 20,220 $ 50 182,868 (162,698)
Beginning balance (in shares) at Dec. 31, 2025 0      
Beginning balance at Dec. 31, 2025 $ 0      
Ending balance (in shares) at Jun. 30, 2026 0      
Ending balance at Jun. 30, 2026 $ 0      
Beginning balance (in shares) at Dec. 31, 2025 46,865,051 46,865,051    
Beginning balance at Dec. 31, 2025 $ 13,260 $ 47 168,878 (155,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercises of stock options (in shares) 287,876      
Net loss $ (14,514)      
Ending balance (in shares) at Jun. 30, 2026 50,032,148 50,032,148    
Ending balance at Jun. 30, 2026 $ 13,166 $ 50 183,295 (170,179)
Beginning balance (in shares) at Mar. 31, 2026 0      
Beginning balance at Mar. 31, 2026 $ 0      
Ending balance (in shares) at Jun. 30, 2026 0      
Ending balance at Jun. 30, 2026 $ 0      
Beginning balance (in shares) at Mar. 31, 2026   49,838,867    
Beginning balance at Mar. 31, 2026 20,220 $ 50 182,868 (162,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Private Placement issuance cost (220)   (220)  
Constructive Dividend (12)   (12)  
Issuance of common stock upon exercises of stock options (in shares)   181,149    
Issuance of common stock upon exercises of stock options 82   82  
Issuance of common stock upon vesting of restricted stock units (in shares)   12,132    
Stock-based compensation 577   577  
Net loss $ (7,481)     (7,481)
Ending balance (in shares) at Jun. 30, 2026 50,032,148 50,032,148    
Ending balance at Jun. 30, 2026 $ 13,166 $ 50 $ 183,295 $ (170,179)